GB2620465A - Synthesis method of indole organophosphorus compound - Google Patents
Synthesis method of indole organophosphorus compound Download PDFInfo
- Publication number
- GB2620465A GB2620465A GB2304417.5A GB202304417A GB2620465A GB 2620465 A GB2620465 A GB 2620465A GB 202304417 A GB202304417 A GB 202304417A GB 2620465 A GB2620465 A GB 2620465A
- Authority
- GB
- United Kingdom
- Prior art keywords
- indole
- compound
- solvent
- mmol
- synthesis method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 indole organophosphorus compound Chemical class 0.000 title claims abstract description 50
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title claims abstract description 22
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 title claims abstract description 21
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 title claims abstract description 21
- 238000001308 synthesis method Methods 0.000 title claims description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 63
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 60
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 51
- 239000002904 solvent Substances 0.000 claims abstract description 41
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 30
- 150000001875 compounds Chemical class 0.000 claims abstract description 23
- 239000003054 catalyst Substances 0.000 claims abstract description 22
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 claims abstract description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 18
- YFPJFKYCVYXDJK-UHFFFAOYSA-N Diphenylphosphine oxide Chemical compound C=1C=CC=CC=1[P+](=O)C1=CC=CC=C1 YFPJFKYCVYXDJK-UHFFFAOYSA-N 0.000 claims abstract description 17
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims abstract description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims abstract description 14
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims abstract description 14
- 229910052751 metal Inorganic materials 0.000 claims abstract description 11
- 239000002184 metal Substances 0.000 claims abstract description 11
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- SBNOTUDDIXOFSN-UHFFFAOYSA-N 1h-indole-2-carbaldehyde Chemical compound C1=CC=C2NC(C=O)=CC2=C1 SBNOTUDDIXOFSN-UHFFFAOYSA-N 0.000 claims abstract description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims abstract description 9
- 229910000024 caesium carbonate Inorganic materials 0.000 claims abstract description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims abstract description 6
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims abstract description 6
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims abstract description 6
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 claims abstract description 5
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 claims abstract description 5
- 235000017550 sodium carbonate Nutrition 0.000 claims abstract description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 claims abstract description 5
- 238000007259 addition reaction Methods 0.000 claims abstract description 4
- 238000005882 aldol condensation reaction Methods 0.000 claims abstract description 4
- 238000006297 dehydration reaction Methods 0.000 claims abstract description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims abstract description 4
- 229910000404 tripotassium phosphate Inorganic materials 0.000 claims abstract description 4
- 235000019798 tripotassium phosphate Nutrition 0.000 claims abstract description 4
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims abstract description 4
- 229910000406 trisodium phosphate Inorganic materials 0.000 claims abstract description 4
- 235000019801 trisodium phosphate Nutrition 0.000 claims abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims description 49
- 239000000047 product Substances 0.000 claims description 46
- 239000012043 crude product Substances 0.000 claims description 26
- 239000000284 extract Substances 0.000 claims description 15
- 238000003818 flash chromatography Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000011541 reaction mixture Substances 0.000 claims description 13
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 claims description 10
- 229940126062 Compound A Drugs 0.000 claims description 6
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 4
- 238000004809 thin layer chromatography Methods 0.000 claims description 4
- 239000002274 desiccant Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 239000000376 reactant Substances 0.000 claims description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 abstract description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 abstract description 3
- 235000015320 potassium carbonate Nutrition 0.000 abstract description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract description 3
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 32
- 101150041968 CDC13 gene Proteins 0.000 description 17
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 17
- 239000003208 petroleum Substances 0.000 description 13
- 239000000758 substrate Substances 0.000 description 12
- 230000008034 disappearance Effects 0.000 description 11
- 238000012544 monitoring process Methods 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 238000004679 31P NMR spectroscopy Methods 0.000 description 9
- 238000005160 1H NMR spectroscopy Methods 0.000 description 7
- 238000005481 NMR spectroscopy Methods 0.000 description 7
- 150000002903 organophosphorus compounds Chemical class 0.000 description 7
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 125000001041 indolyl group Chemical group 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- UZKBSZSTDQSMDR-UHFFFAOYSA-N 1-[(4-chlorophenyl)-phenylmethyl]piperazine Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)N1CCNCC1 UZKBSZSTDQSMDR-UHFFFAOYSA-N 0.000 description 2
- LPGWZGMPDKDHEP-HLTPFJCJSA-N Leurosine Chemical compound C([C@]1([C@@H]2O1)CC)N(CCC=1C3=CC=CC=C3NC=11)C[C@H]2C[C@]1(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC LPGWZGMPDKDHEP-HLTPFJCJSA-N 0.000 description 2
- NSGDYZCDUPSTQT-UHFFFAOYSA-N N-[5-bromo-1-[(4-fluorophenyl)methyl]-4-methyl-2-oxopyridin-3-yl]cycloheptanecarboxamide Chemical compound Cc1c(Br)cn(Cc2ccc(F)cc2)c(=O)c1NC(=O)C1CCCCCC1 NSGDYZCDUPSTQT-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003063 flame retardant Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 229960003048 vinblastine Drugs 0.000 description 2
- YMDXZJFXQJVXBF-STHAYSLISA-L (1R,2S)-epoxypropylphosphonate(2-) Chemical compound C[C@@H]1O[C@@H]1P([O-])([O-])=O YMDXZJFXQJVXBF-STHAYSLISA-L 0.000 description 1
- RNFJDJUURJAICM-UHFFFAOYSA-N 2,2,4,4,6,6-hexaphenoxy-1,3,5-triaza-2$l^{5},4$l^{5},6$l^{5}-triphosphacyclohexa-1,3,5-triene Chemical compound N=1P(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP=1(OC=1C=CC=CC=1)OC1=CC=CC=C1 RNFJDJUURJAICM-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- HTFNVAVTYILUCF-UHFFFAOYSA-N 2-[2-ethoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5-methyl-11-methylsulfonylpyrimido[4,5-b][1,4]benzodiazepin-6-one Chemical compound CCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(c2n1)S(C)(=O)=O)C(=O)N1CCC(CC1)N1CCN(C)CC1 HTFNVAVTYILUCF-UHFFFAOYSA-N 0.000 description 1
- UOXJNGFFPMOZDM-UHFFFAOYSA-N 2-[di(propan-2-yl)amino]ethylsulfanyl-methylphosphinic acid Chemical compound CC(C)N(C(C)C)CCSP(C)(O)=O UOXJNGFFPMOZDM-UHFFFAOYSA-N 0.000 description 1
- VFTRKSBEFQDZKX-UHFFFAOYSA-N 3,3'-diindolylmethane Chemical class C1=CC=C2C(CC=3C4=CC=CC=C4NC=3)=CNC2=C1 VFTRKSBEFQDZKX-UHFFFAOYSA-N 0.000 description 1
- SFHYNDMGZXWXBU-LIMNOBDPSA-N 6-amino-2-[[(e)-(3-formylphenyl)methylideneamino]carbamoylamino]-1,3-dioxobenzo[de]isoquinoline-5,8-disulfonic acid Chemical compound O=C1C(C2=3)=CC(S(O)(=O)=O)=CC=3C(N)=C(S(O)(=O)=O)C=C2C(=O)N1NC(=O)N\N=C\C1=CC=CC(C=O)=C1 SFHYNDMGZXWXBU-LIMNOBDPSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 238000005654 Michaelis-Arbuzov synthesis reaction Methods 0.000 description 1
- LWLSVNFEVKJDBZ-UHFFFAOYSA-N N-[4-(trifluoromethoxy)phenyl]-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methyl]piperidine-1-carboxamide Chemical compound FC(OC1=CC=C(C=C1)NC(=O)N1CCC(CC1)CC1=CC(=CC=C1)OC1=NC=C(C=C1)C(F)(F)F)(F)F LWLSVNFEVKJDBZ-UHFFFAOYSA-N 0.000 description 1
- 241000187391 Streptomyces hygroscopicus Species 0.000 description 1
- 102000004243 Tubulin Human genes 0.000 description 1
- 108090000704 Tubulin Proteins 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 1
- 238000012658 bimolecular nucleophilic substitution Methods 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229960000308 fosfomycin Drugs 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- FGFUBBNNYLNVLJ-UHFFFAOYSA-N indolone Natural products C1=CC=C2C(=O)C=NC2=C1 FGFUBBNNYLNVLJ-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005935 nucleophilic addition reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- YLLIGHVCTUPGEH-UHFFFAOYSA-M potassium;ethanol;hydroxide Chemical compound [OH-].[K+].CCO YLLIGHVCTUPGEH-UHFFFAOYSA-M 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A process for preparing an indole organophosphorus compound, comprising the steps (i) performing in an first solvent an aldol condensation reaction and dehydration reaction between an indole-2-carbaldehyde (A) and an acetophenone (B) in the presence of a base catalyst to provide an indolenoyl compound (C), wherein R1 is selected from 2-Me, 3-Me, 4-Me, 2-Cl, 3-Cl, 4-Cl and H; Ar1 is selected form 2-MeC6H4, 3-MeC6H4, 4-MeC6H4, 3-BrC6H4, 4-MeOC6H4, naphthalene, thionaphthene, furan and pyrrole; and (ii) performing in a second solvent an addition reaction between diphenylphosphine oxide and the indolenoyl compound (C) in the presence of a metal salt catalyst to form the indole organophosphorus compound (D). The first solvent may be selected from ethanol, methanol, dichloromethane, and ethyl acetate. The base catalyst of step (i) may be sodium hydroxide or potassium hydroxide. The second solvent my be selected from dichloromethane, toluene, DMF, and n-hexane. The metal salt catalyst of step (ii) may be selected from Cs2CO3, Na2CO3, NaHCO3, K2CO3, K3PO4, Na3PO4 and Cu(OAc)2. Example compounds prepared include 3-(1,6-dimethyl-1H-indol-2-yl)-3-(diphenylphosphoryl)-1-phenylpropan-1-one; 3-(diphenylphosphoryl)-1-(4-methoxyphenyl)-3-(1-methyl-1H-indol-2-yl)propan-1-one; 1-(benzo[b]thiophen-2-yl)-3-(diphenylphosphoryl)-3-(1-methyl-1H-indol-2-yl)propan-1-one; 3-(diphenylphosphoryl)-3-(1-methyl-1H-indol-2-yl)-1-(1H-pyrrol-2-yl)propan-1-one.
Description
SYNTHESIS METHOD OF INDOLE ORGANOPHOSPHORUS COMPOUND
TECHNICAL FIELD
[0001] The present disclosure belongs to the technical field of organic chemical synthesis, and in particular relates to a synthesis method of an indole organophosphorus compound.
BACKGROUND
[0002] Organophosphorus compounds are widely used in organic synthesis, medicine, pesticides, materials and life sciences because of unique physical and chemical properties thereof With antibacterial, antitumor and other pharmacological activities, phosphorus-containing organic molecules are used as the main active ingredients of drugs such as tissue inhibitors of metalloproteinases (TIMPs), antimalarial drugs, and calcium antagonists. Some organic organophosphorus compounds exist in natural products. For example, Bialaphos is a tripeptide natural product isolated and purified from the fermentation broth of Streptomyces hygroscopicus, which is a non-selective herbicide; Fosfomycin, originally isolated from ASTtreptornyces fintlicle, is effective against Gram-positive and negative bacteria, which is a widely used commercial antibiotic. Organic organophosphorus compounds further play an important role in the field of functional materials. Organophosphorous flame retardants, which have been extensively studied and used, are generally accepted in the field of flame retardant materials because of halogen-free, non-toxic and high-efficiency characteristics thereof [0003] In another aspect, compounds containing indole ring structure exhibit excellent bioactivity in antihypertensive, antiproliferative, antiviral, antitumor, analgesic, anti-inflammatory, and antibacterial drugs due to the unique chemical structure thereof For example, vincaleucoblastine (VLB), a derivative of 3,3'-diindolylmethane, acts on tubulin to affect the mitosis of tumor cells, thereby inhibiting the proliferation of tumor cells. Melatonin is a typical indole hormone, which is a physiological tumor suppressor.
[0004] In view of the importance of organophosphorus compounds and indole ring skeletons, one of the research priorities of organic synthesis and pharmacology is how to efficiently and quickly construct novel molecules containing both organophosphorus and indole ring active units to achieve efficient fusion of active groups, thereby enhancing potential biological activity thereof The Michaelis-Arbuzov reaction developed early is the main method for the synthesis of phosphorus-containing compounds through C-P bond construction, that is, trivalent phosphates and halogenated hydrocarbons undergo bimolecular nucleophilic substitution reaction (SN2) to yield pentavalent alkyl phosphates, but the disadvantages of poor atom economy, harsh reaction conditions, and narrow substrate range limit the application of this reaction in the synthesis of organophosphorus compounds.
100051 P-H bond addition to olefinic bond and acetylenic bond hydrophosphination are an excellent way to construct a C-P bond. Direct construction of organophosphorus compounds phosphorus-hydrogen compounds can avoid the use of phosphorus-halogen reagents sensitive to water and oxygen, and the reaction is higher in atom economy, greener and more environmentally friendly. Such addition reactions are generally carried out under the catalysis of bases, metal catalysts or radical initiators, but these synthesis methods still have defects of expensive catalysts, requirement of anhydrous and oxygen-free reaction conditions, and more by-products.
SUMMARY
[0006] To solve the above problems, an objective of the present disclosure is to provide an efficient, economical and environmentally friendly synthesis method of an indole organophosphorus compound [0007] To achieve the above objective, the present disclosure adopts the following technical solution: 100081 A synthesis method of an indole organophosphorus compound is provided, including the following steps: [0009] step Si, dissolving an indole-2-carbaldehyde compound A and an acetophenone compound B as raw materials in a first solvent, and conducting aldol condensation and dehydration reactions in the presence of a base catalyst to yield an indolenoyl compound C; where 100101 a reaction route is as follows: 100111 Base catalyst First solvent
A
[0012] where R1 is one selected from the group consisting of 2-Me, 3-Me, 4-Me, 2-C1, 3-C1, 4-C1, and 1-1, Ai' is one selected from the group consisting of 2-MeC6H4, 3-MeC6H4, 4-MeC61-14, 3-BrC61-14, 4-Me0C6H4, naphthalene, thianaphthene, furan, and pyrrole; and [0013] step 52, dissolving diphenylphosphine oxide and the indolenoyl compound C obtained in step S1 in a second solvent, and conducting an addition reaction in the presence of a metal salt catalyst to yield a target product D; where [0014] a reaction route is as follows: [0015] p, Metal salt catalyst + Ph b- I
-
Second solvent
N / Ph Ph D.
[0016] Further, in the foregoing step Si, the indole-2-carbaldehyde compound A and the acetophenone compound B may be in a molar ratio of 1:2 to 2:1, and the indole-2-carbaldehyde compound A, the first solvent, and the base catalyst may be used in a ratio of 1 mmol: 5-15 mL. 1-2 mmol.
[0017] Further, in the foregoing step Sl, the first solvent may be one selected from the group consisting of ethanol, methanol, dichloromethane, and ethyl acetate.
[0018] Furthcr, in thc foregoing step Si, the basc catalyst may be a 0.5-1.5 mol/L NaOH or KOH solution.
[0019] Further, in the foregoing step Si, a reaction temperature may be in a range of 0°C to room temperature, and reaction time may be in a range of 1.5-3 h. [0020] Further, in the foregoing step 52, the diphenylphosphine oxide and the indolenoyl compound C may be in a molar ratio of 1:1 to 5:1, and the indolenoyl compound C, the second solvent, and the metal salt catalyst may be used in a ratio of 1 mmol: 2-8 mL: 1-5 mmol. [0021] Further, in the foregoing step S2, the second solvent may be one selected from the group consisting of dichloromethane, toluene, N,N-dimethylformamide, and n-hexane.
[0022] Further, in the foregoing step S2, the metal salt catalyst may be one selected from the group consisting of Cs2CO3, Na2CO3, NaHCO3, K2CO3, K3PO4, Na3PO4, and Cu(OAc)2. [0023] Further, in the foregoing step S2, the reaction temperature may be room temperature, and the reaction time may be in a range of 2-5 h. [0024] Further, according to the synthesis method of an indole organophosphorus compound, in step 52, a reaction process is monitored by thin layer chromatography (TLC), and after reactants completely disappear, a reaction mixture is poured into water and extracted with an extractant, and extracts are combined; the extracts are dried over a desiccant, filtered, and distilled under reduced pressure to obtain a crude product; and the crude product is purified by flash column chromatography to obtain a target compound.
100251 Further, the foregoing extractant may be one selected from the group consisting of dichloromethane, ethyl acetate, ether, and chloroform.
100261 Further, the foregoing desiccant may be one selected from the group consisting of anhydrous sodium sulfate, anhydrous calcium chloride, and anhydrous magnesium sulfate. 100271 Further, during purification by the foregoing flash column chromatography, an eluant may be petroleum ether and ethyl acetate, and the petroleum ether and the ethyl acetate may be in a volume ratio of 1:1.
100281 Because the foregoing technical solution is adopted, the present disclosure has the following advantages: 100291 According to the synthesis method of an indole organophosphorus compound provided by the present disclosure, an indole-2-carbaldehyde compound, as a starting material, undergoes aldol condensation and dehydration reactions with an acetophenone compound to yield asymmetric olefins with an indole skeleton, namely, indolenoyl compounds; a metal salt is used to catalyze the nucleophilic addition reaction of a 2-alkenyl indol one compound with a P-H bond of diphenylphosphine oxide to construct a C(sp3)-P bond to yield an indole organophosphorus compound. With the advantages of wide sources of raw materials, diverse structures, easy operation, low cost, simplicity, safety, mild conditions, rapid reaction, excellent atom economy, high yield, greenness, and high efficiency, the synthesis method has broad application prospects in the field of organic synthesis, providing a new route to synthesise complex phosphine ligands and bioactive organophosphorus compounds.
DETAILED DESCRIPTION OF THE EMBODIMENTS
[0030] The present disclosure can be further described in detail with reference to the following examples; however, the following examples are merely illustrative, and the present disclosure is not limited thereto
100311 Example 1
100321 Step 1, 2 mmol acetophenone compound B1 was added to a 25 mL round-bottomed flask, dissolved with 9 mL of ethanol, slowly added with 4 mL of 0.5 mol/L NaOH solution dropwise at 0°C, and stirred to react at room temperature for 1 h; 2 mmol indole-2-carbaldehyde compound Al was added and stirred to react at room temperature for 1 h, a large amount of yellow solid was formed, filtered, and washed with ethanol, and the solvent was distilled off under reduced pressure to obtain 1 85 mmol indolenoyl compound C I. [0033] the specific reaction formula is: Ethanol [0034] [0035] Al B1 C1 [0036] Step 2, 1.5 mmol diphenylphosphine oxide and 0.5 mmol prepared indolenoyl compound Cl were added to a 25 mL round-bottomed flask, dissolved with 1 mL of dichloromethane, stirred with 1 mmol Cs2CO3 to react at room temperature (rt.) for 2 h; after monitoring the disappearance of the reaction substrate, the reaction mixture was poured into water and extracted thrice with dichloromethane (3 x 10 mL); the extracts were combined, dried over anhydrous sodium sulfate, and filtered, and the solvent was distilled off under reduced pressure to obtain a crude product; the crude product was purified by flash column chromatography, and the eluant was petroleum ether and ethyl acetate in a volume ratio of 1:1; thus, the target product D1 was obtained, with a yield of 92%.
[0037] The specific reaction formula is: 4-Pb CH,CO3 CAI,C1+, E" [0038] Ph/ Ph Cl D1 [0039] The 1H NMR (CDC13, 400 MHz) of the target product Di was as follows: 67.84-7.80 (m, 214), 7.76 (d, J= 7.8, 2H), 7.50-7.38 (m, 41-1), 7.29 (m, 5H), 7.21 (s, 1H), 7.13 (td, J= 7.6, 2.8 Hz, 2H), 6.91 (dd, J= 24, 8.8 Hz, 2H), 6.50 (d, J= 3.2 Hz, 1H), 4.52 (t, J= 8.8 Hz, 1H), 4.06 (ddd, ./= 18.0, 10.4, 4.0 Hz, 1H), 3.46 (ddd, ./-= 18.0, 9.2 2.0 Hz, 1H), 3.24 (s, 3H), and 2.31 (s, 3H); [0040] the 13C NMR (100 MHz, CDCI3) of the target product D1 was as follows: 6 196.70 (d, J = 12.9 Hz), 135.83 (d, 82.4 Hz), 134.65 (d, J= 4.8 Hz), 133.45, 132.35 (d, J = 2.5 Hz), 131.93 (d, = 2.6 Hz), 131.17 (d, ./= 9.1 Hz), 129.02 (d, = 11.2 Hz), 128.58 (d, ./ = 4.3 Hz), 128.21 (d, J= 11.7 Hz), 128.12, 127.72 (d, J= 2.7 Hz), 122.84, 119.95, 108.80, 101.61 (d, J= 5.1 Hz), 39.91, 34.22 (d, J= 70.5Hz), 30.23 (d, J= 110.3 Hz), 21.36; and [0041] the 31P NMR (162 MHz, CDCb) of the target product D1 was as follows: 631.26.
[0042] Example 2
[0043] Step 1, 2 mmol acetophenone compound B2 was added to a 25 mL round-bottomed flask, dissolved with 8 mL of ethanol, slowly added with 1.8 mL of 0.7 mol/L NaOH solution dropwise at 5°C, and stirred to react at room temperature for 1 h; 1 mmol indole-2-carbaldehyde compound A2 was added and stirred to react at room temperature for 50 mm, a large amount of yellow solid was formed, filtered, and washed with ethanol, and the solvent was distilled off under reduced pressure to obtain 0.93 mmol indolenoyl compound C2.
[0044] The specific reaction formula is: NCiH Ethanol [0045] A2 B2 C2 [0046] Step 2,2.0 mmol diphenylphosphine oxide and 1.0 mmol prepared indolenoyl compound C2 were added to a 25 mL round-bottomed flask, dissolved with 3 mL of dichloromethane, stirred with 2.0 mmol Cs2CO3 to react at room temperature (r.t.) for 2.5 h; after monitoring the disappearance of the reaction substrate, the reaction mixture was poured into water and extracted thrice with dichloromethane (3 > 10 mL); the extracts were combined, dried over anhydrous calcium chloride, and filtered, and the solvent was distilled off under reduced pressure to obtain a crude product; the crude product was purified by flash column chromatography, and the eluant was petroleum ether and ethyl acetate in a volume ratio of 1:1; thus, the target product D2 was obtained, with a yield of 93%.
[0047] The specific reaction formula is: [0048] C11C1, + C2 D2 [0049] The 111NMR (400 MHz, CDCI3) of the target product D2 was as follows: 6 7.75-7.81 (m, 2H), 7.75 (d, J 7.6, 211), 7.50-7.39 (m, 5H), 7.32-7.28 (m, 5H), 7.14 (td, J = 7.6, 2.8 Hz, 2H), 6.82 (s, 1H), 6.79 (d, J = 8 Hz, 1H), 6.53 (d, J = 2.4 Hz, 1H), 4.53 (t, J = 8.8 Hz, 1H), 3.96 (ddd, J= 18.0 10.8 4.0 Hz, 1H), 3.46 (ddd,J= 18.0, 9.2, 1.6 Hz, 1H), 3.24 (s H), 2.35 (s, 3H); [0050] the 13C NMR (100 MITz, CDCI3) of the target product D2 was as follows: 6 195.67 (d, J= 12.9 Hz), 136.31 (d, J= 11.2 Hz), 132.92(d, 1=4,5 Hz), 132.38, 131.28 (d, 1=2,3 Hz), 131.93 (d, 1=2.5 Hz), 130.70(d, .1= 7.7 Hz), 120.12 (d, .1= 9.2 Hz), 129.89, 127.97 (d, 11.2 Hz), 127.53, 127.23, 127.11 (d, J=4.3 Hz), 124.51 (d, J=2.1 Hz), 120.09, 118.88, 108.09, 100.97 (d, J= 5.2 Hz), 38.94, 33.04 (d, J= 70.7 Hz), 28.66 (d,J= 68.0 Hz), 20.84; and 100511 the 31P NMR (162 MHz, CDCb) of the target product D2 was as follows: 631.31. [0052] Example 3 [0053] Step 1, 3 mmol acetophenone compound B3 was added to a 25 mL round-bottomed flask, dissolved with 13 mL of methanol, slowly added with 3.0 mL of 1.0 mol/L KOH solution dropwise at 10°C, and stirred to react at room temperature for 1.2 h; 2.5 mmol indole-2-carbaldehyde compound A3 was added and stirred to react at room temperature for 40 min, a large amount of yellow solid was formed, filtered, and washed with ethanol, and the solvent was distilled off under reduced pressure to obtain 2.34 mmol indolenoyl compound C3. [0054] The specific reaction formula is: Kt-At Methanol [0055] A3 B3.3 [0056] Step 2, 2.5 mmol diphenylphosphine oxide and 1.0 mmol prepared indolenoyl compound C3 were added to a 25 mL round-bottomed flask, dissolved with 4 mL of toluene, stirred with 2.0 mmol Na2CO3 to react at room temperature (r.t.) for 2.5 h; after monitoring the disappearance of the reaction substrate, the reaction mixture was poured into water and extracted thrice with ethyl acetate (3 x 10 mL); the extracts were combined, dried over anhydrous sodium sulfate, and filtered, and the solvent was distilled off under reduced pressure to obtain a crude product; the crude product was purified by flash column chromatography, and the eluant was petroleum ether and ethyl acetate in a volume ratio of 1:1; thus, the target product D3 was obtained, with a yield of 91%.
[0057] The specific reaction formula is: [0058] C3 D3 [0059] The 1H NMR (400 MHz, CDC13) of the target product D3 was as follows: 6 7.85-7.81 (m, 2H), 7.77 (d, J= 8.0, 2H), 7.64-7.59 (m, 3H), 7.42-7.38 (m, 4H), 7.30-7.26 (m, 314), 7.157.13 (m, 2H), 6.80 (t, J= 7.6 Hz, 1H), 6.73 (d, J= 6.4 Hz, 1H) 6.56 (s, 1H), 4.53 (t, J= 9.6 Hz, 1H), 3.96 (ddd, J= 18.0, 10.8, 4.0 Hz, 11), 3.51 (s, 3H), 3.46 (dd, J =17.6, 9.2 Hz, 1H), 2.51 (s, 3H); [0060] the 1-3C, NMR (100 MHz, CDC13) of the target product D3was as follows: 5 196.78 (d, J = 13.0Hz), 136.21 (d, J = 11.4 Hz), 134.87(d, J= 4.7 Hz), 133.48 132.39 (d, J = 2.8 Hz), 131.90 (d, .1 = 2.6 Hz), 131.78 (d, .1= 8.4 Hz), 131.20 (d, .7= 11.4 Hz), 130.78 (d, .1= 11.4 Hz), 129.02 (d, J = 3.6 Hz), 128.91 (d, 1= 5.3 Hz), 128.60, 128.46 (d, J = 2.3 Hz), 128.26, 128.14, 124.51, 120.61, 119.41, 118.56, 102.98 (d, J = 5 Hz), 39.78, 34.01 (d, J= 70.3 Hz), 32.06 (d, J= 235.6 Hz), 20.52; and [0061] the 31P NMR (162 MHz, CDCb) of the target product D3 was as follows: 631.51. [0062] Example 4 [0063] Step 1, 2 mmol acetophenone compound B4 was added to a 25 mL round-bottomed flask, dissolved with 12 mL of ethanol, slowly added with 3.5 mL of 1.0 mol/L NaOH solution dropwise at 15°C, and stirred to react at room temperature for 1 h; 2.5 mmol indole-2-carbaldehyde compound A4 was added and stirred to react at room temperature for 1 h, a large amount of yellow solid was formed, filtered, and washed with ethanol, and the solvent was distilled off under reduced pressure to obtain 236 mmol indolenoyl compound C4.
[0064] The specific reaction formula is: [0065] Ethanol A4 B4 C4 [0066] Step 2, 3.5 mmol diphenylphosphine oxide and 1.0 mmol prepared indolenoyl compound C4 were added to a 25 mL round-bottomed flask, dissolved with 3 mL of dichloromethane, stirred with 2.0 mmol Cs2CO3 to react at room temperature (r.t.) for 3 h; after monitoring the disappearance of the reaction substrate, the reaction mixture was poured into water and extracted thrice with ethyl acetate (3 x 10 mL); the extracts were combined, dried over anhydrous sodium sulfate, and filtered, and the solvent was distilled off under reduced pressure to obtain a crude product; the crude product was purified by flash column chromatography, and the eluant was petroleum ether and ethyl acetate in a volume ratio of 1:1; thus, the target product D4 was obtained, with a yield of 89%.
100671 The specific reaction formula is: [00681 (l82C:03 C4 D4 [0069] The NMR (400 MHz, CDC13) of the target product D4 was as follows: 5 7.83-7.77 (m, 4H), 7.55-7.51 (m, 1H), 7.49-7.42 (m, 3H), 7.34-7.29 (m, 5H), 7.18-7.13 (m, 2H), 6.966.93 (m, I= 7.6 Hz, 3H), 6.65 (d, J= 7.0 Hz, 1H), 4.52 (t, 1=9.2 Hz, 1H), 3.98 (ddd, 1= 18.2, 11.2,4.0 Hz, IN), 3.46 (ddd, 1=18.2, 9.2, 2 Hz, 1H), 3.29 (s, 3W; [0070] the I:3C NMR (100 MHz, CDC13) of the target product D4 was as follows: 6 195.57 (d, = 12.8 Hz), 136.61, 135.03, 134.73 (d,1= 5.4 Hz), 132.57, 131.44 (d, J= 2.6 Hz), 131.04 (d, J = 2.6 Hz), 130.73 (d, J = 8.3 Hz), 130.14 (d, J = 11.4 Hz), 128.04 (d, J = 11.2 Hz), 127.62, 127.30 (d, J = 11.7 Hz), 127.12, 125.36, 124.51, 120.733, 118.25, 106.73, 99.64 (d, J = 5.0 Hz), 38.92, 33.36 (d, 1=69.8 Hz), 28.52; and [0071] the 31P NMR (162 MHz, CDC13) of the target product D4 was as follows: 630.93. [0072] Example 5 [0073] Step 1, 4 mmol acetophenone compound B5 was added to a 25 mL round-bottomed flask, dissolved with 15 mL of dichloromethane, slowly added with 2 mL of 1.0 mol/L KOH solution dropwise at 20°C, and stirred to react at room temperature for 1 h; 2 mmol indole-2-carbaldehyde compound AS was added and stirred to react at room temperature for 1.5 h, a large amount of yellow solid was formed, filtered, and washed with ethanol, and the solvent was distilled off under reduced pressure to obtain 1.90 mmol indolenoyl compound C5.
[0074] The specific reaction formula is: [0075] AS B5 C5 [0076] Step 2, 3.0 mmol diphenylphosphine oxide and 1.0 mmol prepared indolenoyl compound C5 were added to a 25 mL round-bottomed flask, dissolved with 4 mL of dichloromethane, stirred with 2.5 mmol Cs2CO3 to react at room temperature (r.t.) for 3.5 h; after monitoring the disappearance of the reaction substrate, the reaction mixture was poured into water and extracted thrice with ether (3 x 10 mL); the extracts were combined, dried over anhydrous magnesium sulfate, and filtered, and the solvent was distilled off under reduced pressure to obtain a crude product; the crude product was purified by flash column chromatography, and the eluant was petroleum ether and ethyl acetate in a volume ratio of 1:1; thus, the target product D5 was obtained, with a yield of 85% [0077] The specific reaction formula is: [0078] Ph-C5 D5 [0079] The 11-1NMR (400 MHz, CDC13) of the target product D5 was as follows: 6 7.81 (t, 8.8Hz, 21-1), 7.50 (d, .1= 7.2 Hz, 1H), 7.46-7.43 (m, 4H), 7.33-7.28 (m, 2H), 7.23-7.19 (t, .1= 7.2 Hz, IR), 7.17-7.08 (m, 4H), 7.05-7.02 (m, 3H), 6.99-6.95 (m, 1H), 6.56 (d, J= 2.4 Hz, tH), 4.52 (t, J= 9.0 Hz, 1H), 3.82 (ddd, J= 18.0, 10.8, 2.4 Hz, 1H), 3.41 (ddd, J=18.0, 9.6,2.4 Hz, 1H), 3.23 (s, 3H), 2.11 (s, 3H); [0080] the 1-3C NMR (100 MHz, CDC13) of the target product D5 was as follows: 6 199.38 (d, J = 14.6 Hz), 137.14, 135.94, 131.31, 130.90, 130.81 (d, J = 7.4 Hz), 130.65 (d, J = 9.3 Hz), 130.15 (d, J= 9.4 Hz), 127.93 (d, J= 10.4 Hz), 124.67, (d, J= 8.3 Hz), 120.22, 119.30, 118.37, 108.03, 101.24, 41.42, 33.57 (d, J= 59.3 Hz), 28.67 (d, .1= 11.4 Hz), 19.94; and [0081] the 31P NMR (162 MHz, CDCb) of the target product D5 was as follows: 630.98. [0082] Example 6 [0083] Step 1, 2 mmol acetophenone compound B6 was added to a 25 mL round-bottomed flask, dissolved with 10 mL of ethanol, slowly added with 2 mL of 0.5 mol/L NaOH solution dropwise at 0°C, and stirred to react at room temperature for 1 h, 1 mmol indole-2-carbal dehyde compound AG was added and stirred to react at room temperature for] h, a large amount of yellow solid was formed, filtered, and washed with ethanol, and the solvent was distilled off under reduced pressure to obtain 095 mmol indolenoyl compound Co. 100841 The specific reaction formula is: AG B6 CO 100861 Step 2, 1.5 mmol diphenylphosphine oxide and 1.0 mmol prepared indolenoyl compound CO were added to a 25 mL round-bottomed flask, dissolved with 1 mL of dichloromethane, stirred with 1 mmol NaHCO3 to react at room temperature (r.t.) for 2 h; after monitoring the disappearance of the reaction substrate, the reaction mixture was poured into water and extracted thrice with dichloromethane (3 x 10 mL), the extracts were combined, dried over anhydrous sodium sulfate, and filtered, and the solvent was distilled off under reduced pressure to obtain a crude product, the crude product was purified by flash column chromatography, and the eluant was petroleum ether and ethyl acetate in a volume ratio of 1:1; thus, the target product D6 was obtained, with a yield of 88%.
100871 The specific reaction formula is: 100881 0 !! -1) Ph Cs2C0;, --N Ph ---1-'IN A C14411, rt. C6 D6
100891 The 1H NMR (400 MHz, CDC13) of the target product D6 was as follows: 67.96-7.83 (m, 2H), 7.66-7.60 (m, 211), 7.60-7.47 (m, 4H), 7.40-7.27 (m, 4H), 7.23 (d, .1 = 7.2 Hz, 1H), 7.17 (td, J = 7.8, 3.0 Hz, 211), 7.13-706(m, 2H), 7.01 (ddd, J = 7.8, 5.6, 2.4 Hz, 1H), 6.69(d, J= 2.8Hz, 1H), 4.61 (t, J= 8.6 Hz, 1H), 4.06 (ddd, J = 18.0, 10.6, 3.6 Hz, 1H), 3.46 (ddd, J= 18.0, 9.4, 2.0 Hz, 1H), 3.34 (s, 3H), and 2.31 (s, 3W; and [0090] the 13C NMR (100 MHz, CDC13) of the target product D6 was as follows: 6196.81 (d, J = 13.2 Hz), 138.46, 136.58 (d, J = 74.5 Hz), 134.70 (d, J = 5.6 Hz), 134.25, 132.37 (d, J = 2.4 Hz), 131.92 (d, J = 2.4 Hz), 131.72 (d, J= 8.4 Hz), 131.05 (d, J = 9.2 Hz), 129.01 (d, J= 11.2 Hz), 128.62 (d, J = 25.0 Hz), 128.21 (d, J = 11.8 Hz), 127.72 (d, J = 2.4 Hz), 125.29, 121.18, 120.30, 119.83, 109.07, 102.18 (d, .1 = 5.0 Hz), 40.01, 33.69 (d, .1 = 71.2 Hz), 29.07, and 21.21; and [0091] the 31P NMR (162 MHz, CDC13) of the target product D6 was as follows 631.46. [0092] Example 7 [0093] Step 1, 2 mmol acetophenone compound B7 was added to a 25 mL round-bottomed flask, dissolved with 15 mL of methanol, slowly added with 2.5 mL of 0.8 mol/L NaOH solution dropwise at 5°C, and stirred to react at room temperature for 1.5 h; 1.5 mmol indole2-carbaldehyde compound A7 was added and stirred to react at room temperature for 1 h, a large amount of yellow solid was formed, filtered, and washed with ethanol, and the solvent was distilled off under reduced pressure to obtain 1.41 mmol indolenoyl compound C7.
[0094] The specific reaction formula is: [0095] A7 B7 C7 [0096] Step 2, 2 mmol diphenylphosphine oxide and 1 mmol prepared indolenoyl compound C7 were added to a 25 mL round-bottomed flask, dissolved with 3 mL of NAdimethylformamide, stirred with 2 mmol Na2CO3 to react at room temperature (r.t.) for 3 h; after monitoring the disappearance of the reaction substrate, the reaction mixture was poured into water and extracted thrice with ethyl acetate (3 >< 10 mL); the extracts were combined, dried over anhydrous calcium chloride, and filtered, and the solvent was distilled off under reduced pressure to obtain a crude product; the crude product was purified by flash column chromatography, and the eluant was petroleum ether and ethyl acetate in a volume ratio of 1:1; thus, the target product D7 was obtained, with a yield of 86%.
[0097] The specific reaction formula is: C7 D7 100991 The 1H NMR (400 MHz, CDCI3) of the target product D7 was as follows: 6 7.91 (t, 8.8Hz, 2H), 7.69 (d, = 8.4 Hz, 2H), 7.62-7.54 (m, 3H), 7.53-7.50 (m, 3H), 7.40-7.30 (m, 3H), 7.20 (td, J = 7.6, 2.8 Hz, 2H), 7.14-7.09 (m, 2H), 7.06-7.02 (m, 1H), 6.67 (d, J = 2.4 Hz, 1H), 4.58 (t, J= 9.2 Hz, 1H), 4.00 (ddd, J= 18.0, 10.8, 4.4 Hz, 1H), 3.47 (ddd, J=18.0, 9.2, 1.6 Hz, 1H), 3.34 (s, 3H); 101001 the 13C NMR (100 MHz, CDCI3) of the target product D7 was as follows: 6 195.80 (d, J = 13.0 Hz), 136.92, 134.51 (d, J = 4.9 Hz), 132.45 (d, J = 2.6 Hz), 132.01 (d, J = 2.6 Hz), 131.73 (d, J= 8.4 Hz), 13110 (d, J= 9.2 Hz), 130.85, 130.49, 129.61, 129.08 (d, J= 11.2 Hz), 128.78, 128.29 (d, 1= 11.6 Hz), 127.64 (d, J= 2.4 Hz), 121.30, 119.45, 109.09, 102.13 (d, .1= 5.1 Hz), 39.87, 34.15 (d, J= 70.2114, 29.08; and 101011 the 31P NMR (162 MHz, CDCI3) of the target product D7 was as follows 631.09. 101021 Example 8 101031 Step 1, 2 mmol acetophenone compound B8 was added to a 50 mL round-bottomed flask, dissolved with 20 mL of ethanol, slowly added with 2.5 mL of 1.0 mol/L KOH solution dropwise at 10°C, and stirred to react at room temperature for 1 h; 2 mmol indole-2-carbaldehyde compound AS was added and stirred to react at room temperature for 1.5 h, a large amount of yellow solid was formed, filtered, and washed with ethanol, and the solvent was distilled off under reduced pressure to obtain 1.86 mmol indolenoyl compound C8.
[0104] The specific reaction formula is: N,N-dimethylformamide, r.t.
[00981 KOH Ethanol [01051 AS B8 C8 1:3 [0106] Step 2, 3 mmol diphenylphosphine oxide and 1 mmol prepared indolenoyl compound C8 were added to a 25 nth round-bottomed flask, dissolved with 2 mL of N,Ardimethylformamide, stirred with 2 mmol K2CO3 to react at room temperature (r.t.) for 3 h; after monitoring the disappearance of the reaction substrate, the reaction mixture was poured into water and extracted thrice with ether (3 < 10 mL); the extracts were combined, dried over anhydrous magnesium sulfate, and filtered, and the solvent was distilled off under reduced pressure to obtain a crude product; the crude product was purified by flash column chromatography, and the eluant was petroleum ether and ethyl acetate in a volume ratio of 1:1; thus, the target product D8 was obtained, with a yield of 84%.
[0107] The specific reaction formula is: [0110] The 1H NMR (400 MHz, CDC13) of the target product D8 was as follows: 67.91 (t, 8.8 Hz, 2H), 7.60 (d, = 6.8 Hz, 1H), 7.57-7.51 (m, 3H), 7.46 (d, = 8.0 Hz, 1H), 7.40-7.28 (m, 5H), 7.23-7.19 (td, J = 7.6, 2.8 Hz, 2H), 7.15-7.09 (m, 2H), 7.06-7.02 (m, 2H), 6.67 (d, J = 2.4 Hz, 1H), 4.61 (t, J= 9.2 Hz, 1H), 3.82 (ddd, J = 18.0, 10.8, 4.0 Hz, 1H), 3.78 (s, 3H), 3.51 (ddd, J = 18.0, 9.6, 1.6 Hz, 1H), and 3.34 (s, 3H); [0111] the 13C NMR (100 MHz, CDCI3) of the target product D8 was as follows: 6 196.56 (d, 1= 13.1 Hz), 159.77, 137.51, 136.93, 134.66 (d, J= 5.1 Hz), 132.40 (d, J 2.7Hz), 131.96 (d, J= 2.6 Hz), 131.75 (d, J= 8.3 Hz), 131.12(d, J = 9.2 Hz), 129.61, 129.05 (d, J= 11.2 Hz), 128.27 (d, J= 11.6 Hz), 127.69(d, J = 2.4 Hz), 121.21, 120.83, 120.29, 119.38, 112.02, 109.08, 102.17 (d, J = 51 Hz), 55.45, 40.07, 34 19, 33.48, 29.71, 29.07; and [0112] the 31P NMR (162 MHz, CDC13) of the target product D8 was as follows: 631.22. [0113] Example 9 [0114] Step 1, 1.5 mmol acetophenone compound B9 was added to a 25 mL round-bottomed flask, dissolved with 12 mL of dichloromethane, slowly added with 2 mL of 1.0 mol/L KOH solution dropwise at 15°C, and stirred to react at room temperature for 1.5 h; 1 mmol indole2-carbaldehyde compound A9 was added and stirred to react at room temperature for 1.5 h, a [0109] C8 D8 N,N-dimethylformamide, r.t.
[0108] large amount of yellow solid was formed, filtered, and washed with ethanol, and the solvent was distilled off under reduced pressure to obtain 0.92 mmol indolenoyl compound C9. [0115] The specific reaction formula is: [0116] A9 B9 C9 [0117] Step 2, 4 mmol diphenylphosphine oxide and 1 mmol prepared indolenoyl compound C9 were added to a 25 mL round-bottomed flask, dissolved with 2 mL of n-hexane, stirred with 3 mmol K3PO4 to react at room temperature (r.t.) for 3.5 h; after monitoring the disappearance of the reaction substrate, the reaction mixture was poured into water and extracted thrice with chloroform (3 10 mL); the extracts were combined, dried over anhydrous magnesium sulfate, and filtered, and the solvent was distilled off under reduced pressure to obtain a crude product; the crude product was purified by flash column chromatography, and the eluant was petroleum ether and ethyl acetate in a volume ratio of 1:1: thus, the target product D9 was obtained, with a yield of 81%.
[0118] The specific reaction formula s: Dichloromethane [0119] K:Pth n-Hexane, r.t. C9 D9
[0120] The 1H NMR (400 MHz, CDC13) of the target product D9 was as follows: S 8.42 (s, 1H), 7.98 (t, ./= 8.4 Hz, 211), 7.91-7.85 (m, 2H), 7.78-7.76 (m, 2H), 7.59-7.48 (m, 6H), 7.38- 7.32 (m, 3H), 7.20-7.16 (td, J = 7.6, 2.8 Hz, 2H), 7.11-7.100, 2H), 7.05-7.00 (m, 1H), 6.78 (d, ./= 2.4 Hz, 1H), 4.69 (t, 1=8.8 Hz, 1H), 4.28 (ddd, .7= 18.0, 11.2, 4.0 Hz, 1H), 3.63 (ddd, J = 17.6, 9.2, 1.2 Hz, 111), 3.72 (s, 3H); [0121] the "C NMR (100 MHz, CDC13) of the target product D9 was as follows: 6 196.56 (d, J = 13.0 Hz), 136.95, 135.69, 134.70 (d, J = 4.7 Hz), 133.45, 132.46 (d, J = 7.6 Hz), 132.37, 129.13 (d, J = 11.2 Hz), 128.75, 128.46, 128.30 (d, J = 11.6 Hz), 127.71, 126.91, 123.48, 121.22, 120.34, 119.40, 109.10, 102.22 (d, J = 5.3 Hz), 39.95, 34.12 (d, J = 70.4 Hz), 29.12; and 101221 the 3113 NMR (162 MHz, CDCI3) of the target product D9 was as follows: 631.52. 101231 Example 10 101241 Step 1, 2 mmol acetophenone compound B10 was added to a 50 mL round-bottomed flask, dissolved with 25 mL of ethanol, slowly added with 2 mL of 1.5 mol/L NaOH solution dropwise at 20°C, and stirred to react at room temperature for 1 h; 2 mmol indole-2-carbaldehyde compound A10 was added and stirred to react at room temperature for 1 h, a large amount of yellow solid was formed, filtered, and washed with ethanol, and the solvent was distilled off under reduced pressure to obtain 1.81 mmol indolenoyl compound C10. 101251 The specific reaction formula is: 10126] A10 B 10 C10 101271 Step 2, 5 mmol diphenylphosphine oxide and 1 mmol prepared indolenoyl compound C10 were added to a 25 mL round-bottomed flask, dissolved with 5 mL of dichloromethane, stirred with 5 mmol Na3PO4 to react at room temperature (r.t.) for 4 h; after monitoring the disappearance of the reaction substrate, the reaction mixture was poured into water and extracted thrice with ethyl acetate (3 x 10 mL); the extracts were combined, dried over anhydrous calcium chloride, and filtered, and the solvent was distilled off under reduced pressure to obtain a crude product; the crude product was purified by flash column chromatography, and the eluant was petroleum ether and ethyl acetate in a volume ratio of 1:1; thus, the target product DID was obtained, with a yield of 73%.
101281 The specific reaction formula is: Nn9PO4 r.t.
N r-Ta) N. Ph
CIO DIO
[0130] The 1H NMR (400 MHz, CDC13) of the target product DID was as follows: 67.89-7.86 (m, 2H), 7.78 (d, J= 8.0 Hz, 1H), 7.72 (d, J= 8.0 Hz, 1H), 7.54-7.45 (m, 4H), 7.37-7.27 (m, 4H), 7.19 (s, 1H), 7.15-7.11 (m, 2H), 7.05-7.02 (m, 2H), 6.98-6.94 (m, 1H), 6.69 (d, .1= 2.4 Hz, 1H), 4.54(t, 1 = 8.8 Hz, 1H), 4.08 (ddd,J= 17.6, 11.2, 4.0 Hz, 111), 3.49 (ddd, 1 = 17.2, 8.8, 1.2 Hz, 1H), and 3.26 (s, 3H); [0131] the 13C NMR (100 MHz, CDC13) of the target product DIO was as follows: 6 190.18, 141.56, 137.90, 136.95, 135.93, 131.45 (d, 1= 2.7 Hz), 130.99 (d,"1 = 2.5 Hz), 130.73 (d, 1= 8.3 Hz), 130.04 (d, .1= 9.2 Hz), 128.46, 128.10 (d, .1= 11.2 Hz), 127.28 (d, I = 11.7 Hz), 126.65, 125.10, 124.05, 121.84, 120.26 119.32, 118.39, 108.08, 101.31, 39.24, 33.10 (d, J= 69.9 Hz), 28.68 (d, J= 63.6 Hz); and [0132] the 31P NMR (162 MHz, CDCb) of the target product D10 was as follows 631.14. [0133] Example 11 [0134] Step 1, 2 mmol acetophenone compound B11 was added to a 50 mL round-bottomed flask, dissolved with 30 mL of ethanol, slowly added with 2.5 mL of 1.5 mol/L NaOH solution dropwise at 20°C, and stirred to react at room temperature for 2.5 h; 2 mmol indole-2-carbaldehyde compound All was added and stirred to react at room temperature for 0.5 h, a large amount of yellow solid was formed, filtered, and washed with ethanol, and the solvent was distilled off under reduced pressure to obtain 1.80 mmol indolenoyl compound C 1 1. [0135] The specific reaction formula is: [0136] All B11 C11 [0137] Step 2, 5 mmol diphenylphosphine oxide and 1 mmol prepared indolenoyl compound C11 were added to a 25 mL round-bottomed flask, dissolved with 8 ml. of toluene, stirred with 3 mmol Cu(OAc)2 to react at room temperature (r.t.) for 3 h; after monitoring the disappearance of the reaction substrate, the reaction mixture was poured into water and extracted thrice with dichloromethane (3 >< 10 mL); the extracts were combined, dried over anhydrous sodium sulfate, and filtered, and the solvent was distilled off under reduced pressure to obtain a crude product; the crude product was purified by flash column chromatography, and the eluant was petroleum ether and ethyl acetate in a volume ratio of 1:1; thus, the target product Dll was obtained, with a yield of 71%.
[0138] The specific reaction formula is:
HN
[0139]
FIN - 0 +-
Cu(OAc)2 r Ph C I I Dll [0140] The Ill NMR (400 MHz, CDCI3) of the target product Dll was as follows: 67.91 (t, 8.8 Hz, 211), 7.61-7.50 (m, 411), 7.39-7.30 (m, 4H), 7.20-7.19 (m, 2H), 7.13-7.07 (m, 211), 7.057.01 (m, 1H), 6.93 (s, IH), 6.88 (s, 111), 6.72 (d, 1= 1.6 Hz, 1H), 6.19 (s, IH), 4.61 (t, = 9.2 Hz, 1H), 3.47 (ddd, J= 16.4, 11.4, 4.0 Hz, 1H), 3.32 (d, 1H), and 3.28 (s, 3H); [0141] the i3C NMR (100 MHz, CDCI3) of the target product DI I was as follows: 6 I 86.3 I (d, .1= 13.2 Hz), 136.90, 132.44 (d, I = 2.3 Hz), 132.02 (d, = 2.9 Hz), 131.81 (d, I = 8.5 Hz), 131.39, 131.08 (d, J= 9.2 Hz), 129.06 (d, J= 11.3 Hz), 128.29 (d, J= 11.6 Hz), 124.88, 121.17, 120.39, 119.33, 116.99, 110.97, 109.03, 102.48, 38.61, 34.05 (d, J = 70.2 Hz), 29.71 (d, J = 69 Hz); and [0142] the 31P NIVIR (162 MHz, CDCI3) of the target product Dll was as follows: 631.99. [0143] The above description is only preferred examples of the present disclosure, and is not intended to limit the present disclosure. Although the present disclosure is expounded with reference to the above examples, a person skilled in the art can still make modifications on the technical solution described in the above examples or equivalent substitutions on some technical features of the technical solution. Any modification, equivalent substitution, and improvement made within the spirit and principle of the present disclosure shall be included within the protection scope of the present disclosure.
Claims (9)
- WHAT IS CLAIMED IS: 1. A synthesis method of an indole organophosphorus compound, comprising the following steps: step SI, dissolving an indole-2-carbaldehyde compound A and an acetophenone compound B as raw materials in a first solvent, and conducting aldol condensation and dehydration reactions in the presence of a base catalyst to yield an indolenoyl compound C; wherein a reaction route is as follows: Base catalyst First solventAwherein RI is one selected from the group consisting of 2-Me, 3-Me, 4-Me, 2-C1, 3-C1, 4-C1, and H; Ai' is one selected from the group consisting of 2-MeC6lLi, 3-MeC6114, 4-MeC61-14, 3-BrC6H4, 4-Me0C6H4, naphthalene, thianaphthene, furan, and pyrrole; and step 52, dissolving diphenylphosphine oxide and the indolenoyl compound C obtained in step 51 in a second solvent, and conducting an addition reaction in the presence of a metal salt catalyst to yield a target product D; wherein a reaction route is as follows: ii P Metal salt catalyst + ph--1 ' ph)N-1 1 N H Second solvent R14N
- N Fr-0 / \ Ph Ph D. 2. The synthesis method of an indole organophosphorus compound according to claim 1, wherein in step S I, the indole-2-carbaldehyde compound A and the acetophenone compound B are in a molar ratio of 1:2 to 2:1, and the indole-2-carbaldehyde compound A, the first solvent, and the base catalyst are used in a ratio of 1 mmol: 5-15 mL* 1-2 mmol.
- 3. The synthesis method of an indole organophosphorus compound according to claim 1 or 2, wherein in step Si, the first solvent is one selected from the group consisting of ethanol, methanol, dichloromethane, and ethyl acetate.
- 4 The synthesis method of an indole organophosphorus compound according to claim 1 or 2, wherein in step Sl, the base catalyst is a 0.5-1.5 mol/L NaOH or KOH solution.
- 5. The synthesis method of an indole organophosphorus compound according to claim 1, wherein in step 51, a reaction temperature is in a range of 0°C to room temperature, and reaction time is in a range of 1.5-3 h.
- 6. The synthesis method of an indole organophosphorus compound according to claim 1, wherein in step S2, the diphenylphosphine oxide and the indolenoyl compound C are in a molar ratio of 1:1 to 5:1, and the indolenoyl compound C, the second solvent, and the metal salt catalyst are used in a ratio of 1 mmol: 2-8 mL-1-5 mmol.
- 7 The synthesis method of an indole organophosphorus compound according to claim 1 or 6, wherein in step S2, the second solvent is one selected from the group consisting of dichloromethane, toluene, N,N-dimethylformamide, and n-hexane.
- 8. The synthesis method of an indole organophosphorus compound according to claim 1 or 6, wherein in step 52, the metal salt catalyst is one selected from the group consisting of Cs2CO3, Na2CO3, NalIC03, 1C2CO3, K3PO4, Na3PO4, and Cu(OAc)2.
- 9. The synthesis method of an indole organophosphorus compound according to claim 1, wherein in step S2, the reaction temperature is room temperature, and the reaction time is in a range of 2-5 h The synthesis method of an indole organophosphorus compound according to claim 1, wherein in step S2, a reaction process is monitored by thin layer chromatography (TLC), and after reactants completely disappear, a reaction mixture is poured into water and extracted with an extractant, and extracts are combined; the extracts are dried over a desiccant, filtered, and distilled under reduced pressure to obtain a crude product; and the crude product is purified by flash column chromatography to obtain a target compound.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210801332.4A CN115010756A (en) | 2022-07-08 | 2022-07-08 | Synthetic method of indole organic phosphine compound |
Publications (2)
Publication Number | Publication Date |
---|---|
GB202304417D0 GB202304417D0 (en) | 2023-05-10 |
GB2620465A true GB2620465A (en) | 2024-01-10 |
Family
ID=83082400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2304417.5A Pending GB2620465A (en) | 2022-07-08 | 2023-03-27 | Synthesis method of indole organophosphorus compound |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN115010756A (en) |
GB (1) | GB2620465A (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5004119B2 (en) * | 2006-08-18 | 2012-08-22 | 国立大学法人東京工業大学 | 2-phthalimido-3-phosphonopropionic acid ester compound and method for producing the same |
CN101805375B (en) * | 2010-03-26 | 2013-12-11 | 中国科学院上海有机化学研究所 | Method for catalyzing and synthesizing chiral phosphine compounds with high enantioselectivity |
CN103709194B (en) * | 2014-01-06 | 2016-06-08 | 苏州鹏旭医药科技有限公司 | The preparation method of the aliphatic phosphate ester of optically active hydroxyl protection |
CN109456362B (en) * | 2018-11-28 | 2020-12-29 | 湖南理工学院 | Novel method for efficiently preparing diaryl methyl substituted organic phosphonate by using P (O) -H compound |
CN110467640B (en) * | 2019-08-30 | 2022-02-25 | 南昌航空大学 | Preparation method of indole or benzimidazole-isoquinolone condensed heterocyclic derivative |
-
2022
- 2022-07-08 CN CN202210801332.4A patent/CN115010756A/en active Pending
-
2023
- 2023-03-27 GB GB2304417.5A patent/GB2620465A/en active Pending
Non-Patent Citations (4)
Title |
---|
Dalton Transactions, vol. 51, no. 21, 2022, pages 8350-8367 * |
Inorganic Chemistry, vol. 60, no. 22, 2021, pages 17276-17287 * |
Synlett, vol. 31, no. 13, 2020, pages 1295-1297 * |
Tetrahedron Letters, vol. 122, 2023, Article No. 154505 * |
Also Published As
Publication number | Publication date |
---|---|
GB202304417D0 (en) | 2023-05-10 |
CN115010756A (en) | 2022-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3459925B1 (en) | Method for preparing 2-hydroxyl-4-(2, 3-disubstituted benzyloxy)-5-substituted benzaldehyde derivative | |
EP0411507B1 (en) | Pyrazole derivatives, their production and use | |
WO1995032190A2 (en) | Pharmaceutical diketopiperazine compounds | |
JP2003040852A (en) | Method for cox-2 inhibitor synthesis | |
US9493494B2 (en) | Phosphinine oxide derivative and preparation method thereof | |
CN112321481B (en) | Chiral indole compound and preparation method thereof | |
MXPA04008110A (en) | Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives. | |
CN115572300A (en) | Synthesis method of sulfonamide substituted polycyclic quinazolinone compound | |
GB2620465A (en) | Synthesis method of indole organophosphorus compound | |
US9670240B2 (en) | Cyclic phosphinate derivatives and method of preparing the same | |
KR100377718B1 (en) | Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors | |
JP4181219B2 (en) | Ring-condensed dihydropyrans, process for their production and use thereof | |
CN112028874B (en) | Synthesis method of eritinib | |
EP0287270A1 (en) | Biologically active compounds | |
CN109232282B (en) | Synthetic method of 2-aminobenzophenone compound | |
JPS6116376B2 (en) | ||
CN114907266B (en) | Preparation method of dihydropyrazole compound | |
KR20140128238A (en) | A novel tubulin polymerization inhibitor, and the synthesizing method thereof | |
CN111777478B (en) | Synthetic method of para-acylaniline sulfonamide compound | |
KR102327657B1 (en) | Novel azulene compounds and its preparation method | |
CN112028800B (en) | Cysteine derivative and synthesis method thereof | |
JP2023176740A (en) | Method for producing organic phosphorus compound | |
US4296128A (en) | Carboxylic acid hydrazides and processes for their manufacture | |
CN108164435B (en) | Green and efficient synthesis method of aryl acrylonitrile compound | |
JPH0256487A (en) | Substituted azacyclohexyl derivative |